Iradimed Corporation

Iradimed Corporation, an Orlando, Florida-based manufacturer of MRI-compatible medical devices, operates as a prime contractor selling non-magnetic infusion pumps, patient monitoring systems, and related medical equipment directly to federal healthcare agencies on full-and-open purchase orders. The company is a small business competing predominantly outside set-asides, though a subset of recent awards carry total small business designations. Iradimed holds no parent IDIQs or GWACs and does not subcontract; all 68 awards in the source record are prime contracts.

Iradimed's federal footprint is concentrated in specialty medical devices for MRI environments where standard hospital equipment cannot safely operate. The company's core product line—the MRidium brand non-magnetic infusion pump system, MRI-safe patient monitors, physiological monitoring equipment, and associated accessories—anchors awards across the Department of Veterans Affairs and the Defense Health Agency. Representative contracts include a $503,196 total small business purchase order from Veterans Integrated Service Network (VISN) 17 in March 2023 for a non-magnetic MRI patient monitor and infusion pump system supporting multiple VA medical centers through July 2027; a $314,198 firm-fixed-price order from the Defense Health Agency in August 2024 for MRidium MRI infusion systems; a $232,227 purchase order from the NIH Clinical Center in September 2026 for MRI infusion pumps; and a $205,117 sole-source order from VISN 22 in September 2026 for MRI-safe IV pump systems with wireless remote controls and DERS software. Maintenance and support contracts represent a secondary revenue stream, including a $48,420 three-year service agreement with the Defense Health Agency for radiology MRI equipment maintenance at Naval Medical Center San Diego and annual software license and training services bundled with system sales.

The customer base is concentrated but dispersed across the VA network and DoD medical facilities. The Defense Health Agency leads by dollar value with 11 awards totaling $1.2 million, followed by VISN 7 (6 awards, $654 thousand), VISN 17 (3 awards, $634 thousand), VISN 22 (8 awards, $448 thousand), and VISN 9 (4 awards, $447 thousand). These five customers account for 55% of combined potential value and represent the only agencies anchoring significant dollars. The breadth of VISNs in the portfolio—26 distinct VISN-level and agency-level customers across 68 awards—reflects fragmented VA purchasing across medical center supply chains rather than concentration at a single contracting office. The National Institutes of Health, National Institute of Mental Health, and Air Mobility Command round out the customer set with occasional single or dual awards. All awards are NAICS 339112 (Surgical and Medical Instrument Manufacturing) or NAICS 811212 (Electronic and Precision Equipment Repair and Maintenance) procurement; the PSC codes are Medical And Surgical Instruments, Equipment, And Supplies (44 awards) or Maintenance/Repair/Rebuild of Medical Equipment (10 awards).

Activity has grown to 12 awards in 2026 after a slowdown in 2025 (2 awards), suggesting recovery in federal healthcare device purchasing or seasonal contract timing. The company faces a recompete cliff of nine awards worth $1.4 million in combined potential value completing within the next twenty-four months, including VISN 17's multi-year monitor and pump system order (July 2027), a VISN 7 MRI monitor contract (July 2027), and several shorter-term VISN maintenance and supply agreements. Sole-source justifications recur across the award record, grounded in Iradimed's exclusive manufacture of non-magnetic MRI infusion pump technology meeting federal healthcare standards—a technical defensibility that has sustained contract awards despite the lack of IDV or GWAC participation.